
Vericel Corp
VCELHealthcare|Biotechnology|USA
$47.00
-1.32 (-2.73%)
DCF (FCF)
$9.33
Tangible Book
$6.88
Graham Number
$8.06
Earnings Power
$1.32
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (185)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| SIEGAL JONATHAN | Principal Accounting Officer | 2026-06-26 | SELL | 2,732 | $44.9 | $122.7K |
| Mara Joseph Anthony Jr | CFO | 2026-06-26 | SELL | 5,000 | $44.75 | $223.8K |
| Hopper Jonathan Mark | Chief Medical Officer | 2026-06-26 | SELL | 10,000 | $45 | $450K |
| Flynn Sean C. | Chief Legal Officer | 2026-06-26 | SELL | 15,000 | $45.64 | $684.6K |
| Halpin Michael | COO | 2026-06-18 | SELL | 10,000 | $40.24 | $402.4K |
| Flynn Sean C. | Chief Legal Officer | 2026-06-18 | SELL | 15,000 | $40.21 | $603.2K |
| Hopper Jonathan Mark | Chief Medical Officer | 2026-06-02 | SELL | 4,375 | $35 | $153.1K |
| MCLAUGHLIN KEVIN F | Director | 2026-05-13 | SELL | 7,000 | $32.83 | $229.8K |
| Wotton Paul K | Director | 2026-05-11 | SELL | 10,000 | $32.74 | $327.4K |
| Mara Joseph Anthony Jr | CFO | 2026-05-07 | SELL | 5,000 | $40.5 | $202.5K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2026-05-07 | SELL | 4,855 | $38.73 | $188K |
| Hopper Jonathan Mark | Chief Medical Officer | 2026-04-02 | SELL | 3,472 | $35 | $121.5K |
| Hagen Heidi | Director | 2026-03-23 | SELL | 15,000 | $32.41 | $486.2K |
| Flynn Sean C. | Chief Legal Officer | 2026-03-02 | SELL | 21,421 | $35.18 | $753.6K |
| Halpin Michael | COO | 2026-03-02 | SELL | 10,305 | $35.3 | $363.8K |
| MCLAUGHLIN KEVIN F | Director | 2026-02-11 | SELL | 7,000 | $34.66 | $242.6K |
| Halpin Michael | COO | 2026-01-07 | SELL | 10,000 | $40.48 | $404.8K |
| Wotton Paul K | Director | 2025-12-03 | SELL | 5,000 | $37.9 | $189.5K |
| Hopper Jonathan Mark | Chief Medical Officer | 2025-12-02 | SELL | 1,652 | $39.14 | $64.7K |
| Halpin Michael | COO | 2025-11-11 | SELL | 2,642 | $40.41 | $106.8K |
| MCLAUGHLIN KEVIN F | Director | 2025-11-10 | SELL | 7,000 | $38.59 | $270.1K |
| Halpin Michael | COO | 2025-11-06 | SELL | 7,358 | $40.47 | $297.8K |
| Hopper Jonathan Mark | Chief Medical Officer | 2025-09-02 | SELL | 10,000 | $35.77 | $357.7K |
| MCLAUGHLIN KEVIN F | Director | 2025-08-06 | SELL | 7,000 | $35.92 | $251.4K |
| Hopper Jonathan Mark | Chief Medical Officer | 2025-06-02 | SELL | 10,000 | $40.09 | $400.9K |
| Colangelo Dominick | President and CEO | 2025-05-15 | SELL | 28,125 | $41.89 | $1178.2K |
| MCLAUGHLIN KEVIN F | Director | 2025-05-07 | SELL | 7,000 | $39.98 | $279.9K |
| Colangelo Dominick | President and CEO | 2025-04-10 | SELL | 49,700 | $41.5 | $2062.6K |
| Colangelo Dominick | President and CEO | 2025-03-13 | SELL | 53,183 | $46.04 | $2448.5K |
| Flynn Sean C. | Chief Legal Officer | 2025-02-25 | SELL | 1,669 | $52.07 | $86.9K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2025-02-25 | SELL | 1,137 | $52.07 | $59.2K |
| Flynn Sean C. | Chief Legal Officer | 2025-02-20 | SELL | 3,835 | $57.32 | $219.8K |
| MCLAUGHLIN KEVIN F | Director | 2025-02-12 | SELL | 7,000 | $55.46 | $388.2K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2025-02-05 | SELL | 1,092 | $61.99 | $67.7K |
| ZERBE ROBERT L MD | Director | 2025-02-05 | SELL | 2,500 | $62.5 | $156.3K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2025-01-28 | SELL | 3,908 | $61.99 | $242.3K |
| Wotton Paul K | Director | 2024-12-04 | SELL | 2,600 | $58.72 | $152.7K |
| Hopper Jonathan Mark | Chief Medical Officer | 2024-12-02 | SELL | 10,000 | $58.72 | $587.2K |
| ZERBE ROBERT L MD | Director | 2024-11-22 | SELL | 2,500 | $60 | $150K |
| Colangelo Dominick | President and CEO | 2024-11-14 | SELL | 35,000 | $54.75 | $1916.3K |
| MCLAUGHLIN KEVIN F | Director | 2024-11-13 | SELL | 7,000 | $55.54 | $388.8K |
| ZERBE ROBERT L MD | Director | 2024-11-12 | SELL | 5,000 | $56.25 | $281.3K |
| Colangelo Dominick | President and CEO | 2024-10-17 | SELL | 35,000 | $40.86 | $1430.1K |
| GILMAN STEVEN C | Director | 2024-10-16 | SELL | 5,833 | $41.36 | $241.3K |
| GILMAN STEVEN C | Director | 2024-10-02 | SELL | 5,833 | $40.35 | $235.4K |
| GILMAN STEVEN C | Director | 2024-09-18 | SELL | 5,834 | $45.54 | $265.7K |
| Colangelo Dominick | President and CEO | 2024-09-12 | SELL | 35,000 | $43.64 | $1527.4K |
| GILMAN STEVEN C | Director | 2024-09-04 | SELL | 5,000 | $48.58 | $242.9K |
| Hopper Jonathan Mark | Chief Medical Officer | 2024-09-03 | SELL | 10,000 | $49.83 | $498.3K |
| Colangelo Dominick | President and CEO | 2024-08-15 | SELL | 35,000 | $45.71 | $1599.9K |
| MCLAUGHLIN KEVIN F | Director | 2024-08-07 | SELL | 7,000 | $45.94 | $321.6K |
| Colangelo Dominick | President and CEO | 2024-07-18 | SELL | 35,000 | $51.48 | $1801.8K |
| Flynn Sean C. | Chief Legal Officer | 2024-07-16 | SELL | 15,000 | $52.18 | $782.7K |
| Mara Joseph Anthony Jr | CFO | 2024-07-12 | SELL | 5,000 | $50 | $250K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2024-07-05 | SELL | 545 | $45 | $24.5K |
| Flynn Sean C. | Chief Legal Officer | 2024-06-24 | SELL | 15,000 | $45.11 | $676.7K |
| Colangelo Dominick | President and CEO | 2024-06-13 | SELL | 35,000 | $43.61 | $1526.4K |
| Hopper Jonathan Mark | Chief Medical Officer | 2024-05-20 | SELL | 10,000 | $49.99 | $499.9K |
| Colangelo Dominick | President and CEO | 2024-05-16 | SELL | 35,000 | $48.76 | $1706.6K |
| Colangelo Dominick | President and CEO | 2024-04-18 | SELL | 35,000 | $45.53 | $1593.6K |
| ZERBE ROBERT L MD | Director | 2024-03-27 | SELL | 3,278 | $51.57 | $169K |
| Colangelo Dominick | President and CEO | 2024-03-14 | SELL | 35,000 | $44.35 | $1552.3K |
| Halpin Michael | COO | 2024-03-11 | SELL | 7,874 | $44.71 | $352K |
| Flynn Sean C. | SVP, General Counsel | 2024-03-08 | SELL | 8,115 | $45.33 | $367.9K |
| Flynn Sean C. | SVP, General Counsel | 2024-03-08 | SELL | 8,115 | $45.33 | $367.9K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2024-03-07 | SELL | 1,634 | $45 | $73.5K |
| ZERBE ROBERT L MD | Director | 2024-02-20 | SELL | 722 | $50.01 | $36.1K |
| Colangelo Dominick | President and CEO | 2024-02-15 | SELL | 35,000 | $47.92 | $1677.2K |
| ZERBE ROBERT L MD | Director | 2024-01-29 | SELL | 2,300 | $44.22 | $101.7K |
| ZERBE ROBERT L MD | Director | 2024-01-25 | SELL | 200 | $44.02 | $8.8K |
| ZERBE ROBERT L MD | Director | 2024-01-22 | SELL | 8,000 | $41.85 | $334.8K |
| Colangelo Dominick | President and CEO | 2024-01-18 | SELL | 33,452 | $38.28 | $1280.5K |
| ZERBE ROBERT L MD | Director | 2024-01-12 | SELL | 2,200 | $38.09 | $83.8K |
| Flynn Sean C. | SVP, General Counsel | 2023-12-14 | SELL | 1,538 | $34.42 | $52.9K |
| Wotton Paul K | Director | 2023-12-14 | SELL | 5,000 | $37.31 | $186.6K |
| Colangelo Dominick | President and CEO | 2023-12-14 | SELL | 24,000 | $35.58 | $853.9K |
| Colangelo Dominick | President and CEO | 2023-12-07 | SELL | 24,397 | $34.14 | $832.9K |
| Halpin Michael | COO | 2023-11-30 | SELL | 17,447 | $35.41 | $617.8K |
| Hopper Jonathan Mark | Chief Medical Officer | 2023-11-20 | SELL | 5,000 | $36.4 | $182K |
| ZERBE ROBERT L MD | Director | 2023-11-15 | SELL | 300 | $38.02 | $11.4K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2023-11-15 | SELL | 662 | $37.7 | $25K |
| ZERBE ROBERT L MD | Director | 2023-07-14 | SELL | 1,000 | $38.84 | $38.8K |
| ZERBE ROBERT L MD | Director | 2023-06-22 | SELL | 3,000 | $36 | $108K |
| Colangelo Dominick | President and CEO | 2023-01-10 | SELL | 39,938 | $27.13 | $1083.5K |
| SIEGAL JONATHAN | Principal Accounting Officer | 2022-10-14 | SELL | 331 | $25.47 | $8.4K |
| GILMAN STEVEN C | Director | 2022-04-29 | SELL | 900 | $30.94 | $27.8K |
| Hopper Jonathan Mark | Chief Medical Officer | 2021-12-22 | SELL | 15,881 | $40.11 | $637K |
| GILMAN STEVEN C | Director | 2021-11-29 | SELL | 5,000 | $39.17 | $195.9K |
| GILMAN STEVEN C | Director | 2021-10-27 | SELL | 5,000 | $50.57 | $252.9K |
| Halpin Michael | COO | 2021-10-26 | SELL | 10,000 | $50.57 | $505.7K |
| GILMAN STEVEN C | Director | 2021-09-30 | SELL | 5,000 | $48.85 | $244.3K |
| Flynn Sean C. | VP, General Counsel | 2021-08-27 | SELL | 7,200 | $55.11 | $396.8K |
| Halpin Michael | COO | 2021-08-16 | SELL | 15,000 | $48.03 | $720.5K |
| Flynn Sean C. | VP, General Counsel | 2021-07-21 | SELL | 2,800 | $55.01 | $154K |
| Flynn Sean C. | VP, General Counsel | 2021-07-15 | SELL | 10,000 | $51.18 | $511.8K |
| Halpin Michael | COO | 2021-07-12 | SELL | 20,000 | $53.54 | $1070.8K |
| Wotton Paul K | Director | 2021-05-12 | SELL | 15,648 | $49.94 | $781.5K |
| Colangelo Dominick | President and CEO | 2021-04-19 | SELL | 40,000 | $58.01 | $2320.4K |
| Hopper Jonathan Mark | Chief Medical Officer | 2021-03-30 | SELL | 17,924 | $51.4 | $921.3K |
| Colangelo Dominick | President and CEO | 2021-03-29 | SELL | 40,000 | $51.01 | $2040.4K |
| Hopper Jonathan Mark | Chief Medical Officer | 2020-12-21 | SELL | 24,235 | $26.54 | $643.2K |
| Halpin Michael | COO | 2020-12-21 | SELL | 30,000 | $26.28 | $788.4K |
| ZERBE ROBERT L MD | Director | 2020-11-23 | SELL | 17,500 | $23.55 | $412.1K |
| Halpin Michael | COO | 2020-06-23 | SELL | 14,751 | $15.01 | $221.4K |
| Halpin Michael | COO | 2020-06-16 | SELL | 4,002 | $15 | $60K |
| Halpin Michael | COO | 2019-11-11 | SELL | 15,047 | $18.53 | $278.8K |
| Colangelo Dominick | President and CEO | 2019-10-01 | SELL | 58,125 | $14.88 | $864.9K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-08-14 | SELL | 17,000 | $16.62 | $282.5K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-07-15 | SELL | 17,000 | $19.68 | $334.6K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-06-10 | SELL | 17,500 | $15.62 | $273.4K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-05-13 | SELL | 17,500 | $17.02 | $297.9K |
| GILMAN STEVEN C | Director | 2019-05-01 | SELL | 7,500 | $16.81 | $126.1K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-04-08 | SELL | 15,625 | $17.64 | $275.6K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-03-11 | SELL | 10,000 | $20.02 | $200.2K |
| GILMAN STEVEN C | Director | 2019-02-28 | SELL | 7,500 | $18.02 | $135.2K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-02-11 | SELL | 10,000 | $17.09 | $170.9K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2019-01-14 | SELL | 8,711 | $17.18 | $149.7K |
| Wotton Paul K | Director | 2019-01-02 | SELL | 22,500 | $16.83 | $378.7K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2018-12-10 | SELL | 15,625 | $16.81 | $262.7K |
| GILMAN STEVEN C | Director | 2018-12-03 | SELL | 8,500 | $17.75 | $150.9K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2018-11-12 | SELL | 15,000 | $15.9 | $238.5K |
| Colangelo Dominick | President and CEO | 2018-11-06 | SELL | 50,000 | $15.39 | $769.5K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2018-10-15 | SELL | 15,000 | $12.65 | $189.8K |
| Colangelo Dominick | President and CEO | 2018-10-04 | SELL | 75,000 | $15.02 | $1126.5K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2018-09-10 | SELL | 15,000 | $12.35 | $185.3K |
| GILMAN STEVEN C | Director | 2018-09-04 | SELL | 9,000 | $12.03 | $108.3K |
| Wotton Paul K | Director | 2018-06-18 | SELL | 30,000 | $12.06 | $361.8K |
| Colangelo Dominick | President and CEO | 2018-05-17 | SELL | 28,886 | $14.01 | $404.7K |
| Orlando Daniel | COO | 2018-05-10 | SELL | 34,183 | $13.04 | $445.7K |
| Rubino Alan L | Director | 2018-03-16 | BUY | 890 | $11.57 | $10.3K |
| Consonance Capital Management | 10% Owner | 2016-03-28 | SELL | 120,000 | $5.39 | $646.8K |
| MICHEL GERARD J | CFO and VP, Corp. Development | 2014-09-16 | BUY | 20,000 | $2.55 | $51K |
| Colangelo Dominick | President and CEO | 2014-09-16 | BUY | 20,000 | $2.55 | $51K |
| Orlando Daniel | COO | 2014-09-16 | BUY | 9,804 | $2.55 | $25K |
| Durbin Scott | CFO | 2012-01-04 | SELL | 2,000 | $36 | $72K |
| Durbin Scott | CFO | 2011-08-11 | BUY | 543 | $44.8 | $24.3K |
| CRESSWELL RONALD M | Director | 2011-08-11 | BUY | 1,000 | $44.4 | $44.4K |
| MAYLEBEN TIMOTHY M | President and CEO | 2011-08-08 | BUY | 500 | $42.2 | $21.1K |
| MAYLEBEN TIMOTHY M | President and CEO | 2011-08-05 | BUY | 1,000 | $47.2 | $47.2K |
| CRESSWELL RONALD M | Director | 2011-03-24 | BUY | 1,000 | $43.8 | $43.8K |
| Durbin Scott | CFO | 2011-03-04 | BUY | 677 | $43.4 | $29.4K |
| MAYLEBEN TIMOTHY M | CEO and President | 2011-03-03 | BUY | 1,069 | $42.4 | $45.3K |
| MAYLEBEN TIMOTHY M | CEO & President | 2010-11-24 | BUY | 600 | $43.8 | $26.3K |
| MAYLEBEN TIMOTHY M | CEO and President | 2010-08-30 | BUY | 860 | $29 | $24.9K |
| Durbin Scott | CFO | 2010-08-26 | BUY | 823 | $29 | $23.9K |
| MAYLEBEN TIMOTHY M | CEO, President, CFO & Director | 2010-05-21 | BUY | 880 | $28.4 | $25K |
| DUNBAR GEORGE W JR | Director | 2010-03-10 | BUY | 450 | $31.2 | $14K |
| MAYLEBEN TIMOTHY M | CEO, President, CFO & Director | 2010-03-08 | BUY | 1,698 | $29.2 | $49.6K |
| DUNBAR GEORGE W JR | President & CEO, Director | 2007-11-12 | BUY | 125 | $144 | $18K |
| Brennan Gerald JR | VP Admin. and Finance, CFO | 2007-11-12 | BUY | 125 | $150.4 | $18.8K |
| SIMS NELSON M | Director | 2007-11-12 | BUY | 63 | $144 | $9K |
| SUDOVAR STEPHEN | Director | 2007-09-14 | BUY | 63 | $179.2 | $11.2K |
| ARMSTRONG R DOUGLAS PHD | Chairman and CEO | 2006-06-06 | BUY | 50 | $201.6 | $10.1K |
| SUDOVAR STEPHEN | Director | 2006-05-18 | BUY | 63 | $219.2 | $13.7K |
| Hock Janet Mary | VP Global Research & CSO | 2006-05-12 | SELL | 232 | $217.6 | $50.5K |
| Brennan Gerald JR | VP Admin. & Finance, CFO | 2006-02-16 | BUY | 63 | $280 | $17.5K |
| ARMSTRONG R DOUGLAS PHD | CEO and Chairman of the Board | 2006-02-13 | BUY | 19 | $267.2 | $5K |
| FINGERLE LINDA M | Former Director | 2005-12-20 | SELL | 131 | $371.2 | $48.7K |
| FINGERLE LINDA M | Director | 2005-08-17 | BUY | 2 | $446.4 | $1K |
| FINGERLE LINDA M | Director | 2005-07-20 | BUY | 2 | $499.2 | $1K |
| FINGERLE LINDA M | Director | 2005-06-22 | BUY | 2 | $451.2 | $1K |
| ARMSTRONG R DOUGLAS PHD | Chairman, CEO | 2005-05-20 | SELL | 751 | $457.6 | $343.7K |
| FINGERLE LINDA M | Director | 2005-05-18 | BUY | 3 | $320 | $1K |
| ARMSTRONG R DOUGLAS PHD | Chairman, CEO | 2005-05-18 | SELL | 3,588 | $376 | $1349.1K |
| FINGERLE LINDA M | Director | 2005-04-20 | BUY | 3 | $356.8 | $1K |
| FINGERLE LINDA M | Director | 2005-03-16 | BUY | 2 | $422.4 | $1K |
| HAMPSON BRIAN | VP Product Develop | 2005-03-03 | SELL | 94 | $451.2 | $42.3K |
| ARMSTRONG R DOUGLAS PHD | Chairman and CEO | 2005-02-23 | SELL | 2,338 | $473.6 | $1107.3K |
| FINGERLE LINDA M | Director | 2005-02-16 | BUY | 2 | $449.6 | $1K |
| FINGERLE LINDA M | Director | 2005-01-19 | BUY | 1 | $416 | $0.2K |
| FINGERLE LINDA M | Director | 2004-12-22 | BUY | 1 | $176 | $0.2K |
| FINGERLE LINDA M | Director | 2004-11-17 | BUY | 2 | $152 | $0.2K |
| FINGERLE LINDA M | Director | 2004-10-20 | BUY | 2 | $163.2 | $0.2K |
| FINGERLE LINDA M | Director | 2004-09-22 | BUY | 4 | $142.4 | $0.5K |
| FINGERLE LINDA M | Director | 2004-08-18 | BUY | 5 | $110.4 | $0.5K |
| FINGERLE LINDA M | Director | 2004-07-21 | BUY | 4 | $139.2 | $0.5K |
| CAMPBELL MARY L | Director | 2004-07-21 | BUY | 2 | $139.2 | $0.2K |
| CAMPBELL MARY L | Director | 2004-06-16 | BUY | 2 | $158.4 | $0.3K |
| FINGERLE LINDA M | Director | 2004-06-16 | BUY | 3 | $158.4 | $0.5K |
| FINGERLE LINDA M | Director | 2004-05-24 | BUY | 4 | $140.8 | $0.5K |
| CAMPBELL MARY L | Director | 2004-04-24 | BUY | 2 | $140.8 | $0.3K |
| FINGERLE LINDA M | Director | 2004-04-21 | BUY | 2 | $180.8 | $0.4K |
| CAMPBELL MARY L | Director | 2004-04-21 | BUY | 1 | $180.8 | $0.2K |
| CAMPBELL MARY L | Director | 2004-03-17 | BUY | 1 | $212.8 | $0.2K |
| FINGERLE LINDA M | Director | 2004-03-03 | BUY | 6 | $246.4 | $1.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked